Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Undecaprenyl pyrophosphate (UPP), also known as C55-isoprenyl pyrophosphate or bactoprenol pyrophosphate, is an essential lipid carrier in bacteria that transports peptidoglycan precursors across the cytoplasmic membrane (Manat et al., 2014, PubMed: 25100633). After delivering the precursor to the cell wall assembly site, UPP must be dephosphorylated by undecaprenyl pyrophosphate phosphatases, such as UppP (BacA), to regenerate undecaprenyl phosphate (UP) for further transport cycles (El Ghachi et al., 2004, PubMed: 15251211). This dephosphorylation step is a critical bottleneck in bacterial cell wall synthesis. The antibiotic bacitracin targets this process by forming a complex with UPP in the presence of divalent metal ions, which prevents the phosphatase from acting on the substrate (Stone and Strominger, 1971, PubMed: 4328831). This sequestration leads to the depletion of the available lipid carrier pool, effectively halting cell wall production and causing bacterial cell death. Because this lipid-mediated transport system is unique to prokaryotes, it serves as a specific target for antimicrobial therapy, although the systemic toxicity of bacitracin limits its clinical use to topical applications (StatPearls, 2023).
Bacitracin binds to undecaprenyl pyrophosphate in a metal-dependent manner, preventing its dephosphorylation by undecaprenyl pyrophosphate phosphatase and thereby blocking the recycling of the lipid carrier essential for cell wall synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Undecaprenyl pyrophosphate and undecaprenyl pyrophosphate phosphatase (UPP/UPP phosphatase).